NEW YORK, Aug. 1, 2011 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter
↧
American Oriental Bioengineering to Announce Second Quarter 2011 Financial Results on August 9, 2011
↧